As featured in…
Latest Press Releases
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
Company surpasses $3M in accepted investments CHICAGO – September 16, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced it has modified its Regulation A+ (Mini-IPO) offering following a successful September re-launch. BIOLIFE4D has raised more than $3M in equity crowdfunding investments since February of 2018. …
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO – September 9, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its…
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…
Recent Blogs
Debunking Organ Donation Myths
In the United States alone, roughly 20 people die each day waiting for a lifesaving organ transplant. Every 10 minutes, a new name is added to the donor organ waitlist, with over 114,000 people currently on the list. Globally, we’ve been witnessing the shortage of organs available for transplant and the number of individuals waiting is only…
Have a Happy and (Heart) Healthy New Year!
It’s officially a new year and you know what that means- a time where many people create resolutions. If you’ve ever created a New Year’s resolution that slipped under the cracks, you’re not the only one. This year, we suggest focusing on the long-term goals where improving matters the most. Short-term goals could be beneficial,…
2019 Brought Us One Step Closer!
2019 was an incredibly exciting year for us at BIOLIFE4D – so much so that we wanted to share some of our proudest accomplishments as we head in to 2020! The continued support we have received from our investors, the scientific community, and the general public has been tremendous and has pushed us one step…
BIOLIFE4D in the News!
This Company Has Our Hearts – Steven Morris – BIOLIFE4D
Be in the know about BIOLIFE4D and the progress made so far – this is the company that has our hearts! To learn more, CLICK HERE.
BIOLIFE4D CEO Says Firm ‘One Step Closer’ to 3D Printing a Viable Human Heart
By Spencer Feingold | Oct 9 | Cheddar An Illinois-based biomedical technology firm, BIOLIFE4D, reached a watershed moment last month after successfully 3D bioprinting a miniaturized human heart. While not intended for human transplants, the mini heart was a major breakthrough in bioprinting and is expected to have broad implications for pharmaceutical testing. To Read…
A Chicago Biotech Startup’s “Mini-Heart” Could Mean Big Things for 3D Bioprinting
By Steven Ghosett, Sept. 6, 2019 “Our goal is to have this technology available to the people that need it the most and provide a life-saving option for these patients,” he said. “As with any new technology, it should be monitored so it’s not exploited for the wrong purposes.” To reach more, CLICK HERE.
BIOLIFE4D OVERVIEW
PRESS KIT
BIOLIFE4D welcomes the opportunity to speak with the media about bioprinting, its equity crowdfunding raise efforts and how building hearts will save lives.
